Industry officials plan to find places to cooperate with Trump’s choice to run the Health and Human Services department.

RFK Jr., a prominent vaccine skeptic, wants to make many changes to the U.S. food and drug system as head of the HHS. Here's a snapshot.

We’re staring down the barrel of another Trump presidential term, and this time around, the president-elect isn’t wasting any time in rewarding his allies with Cabinet posts. Most recently, Trump announced his plan to nominate Robert F.

Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination will affect the Food and Drug Administration.

Here are the debunked health claims that Robert F. Kennedy Jr. has made over the years that concern medical experts.

President-elect Donald Trump said this week he’s nominating Robert F. Kennedy Jr. — who was running for president himself not too long ago — to oversee the Department of Health and Human

The news prompted a sell-off across the industry. In the US, shares in Pfizer and Moderna sank more than 5% in early trading, while UK-listed firms AstraZeneca and GSK dropped 2% or more. Russ Mould, investment director at AJ Bell, said the pick had “spooked” shareholders, despite questions about how the new administration might pursue its threats.

"We have a generational opportunity to bring together the greatest minds in science, medicine, industry, and government to put an end to the chronic disease epidemic," Kennedy said.

Donald Trump has tapped vaccine-skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.

CNN’s Dr. Sanjay Gupta, a brain surgeon, said “there’s a lot of concern” in the medical community about former independent presidential candidate Robert F. Kennedy Jr. having a larger role in the Trump administration,

After his 2008 victory over John McCain, Obama's team viewed Kennedy as a leading candidate for EPA Administrator, a key role in enforcing environmental laws.